Astrazeneca PLC (AZN) RNS Announcements | Ticker | Ticker

Astrazeneca PLC (AZN) RNS Announcements | Ticker | Ticker

Date	Time	Date	TitleTitle (filtered)
03/09/21	07:00:06	3 Sept 2021	Ultomiris approved in EU for children with PNH	Ultomiris approved in EU for children with PNH
01/09/21	15:00:06	1 Sept 2021	Total Voting Rights	Total Voting Rights
26/08/21	07:05:00	26 Aug 2021	Forxiga approved in Japan for CKD	Forxiga approved in Japan for CKD
26/08/21	07:00:02	26 Aug 2021	ALXN1840 Wilson Phase III met primary endpoint	ALXN1840 Wilson Phase III met primary endpoint
20/08/21	07:05:04	20 Aug 2021	Update on Ultomiris Phase III ALS trial	Update on Ultomiris Phase III ALS trial
20/08/21	07:00:09	20 Aug 2021	AZD7442 prophylaxis trial met primary endpoint	AZD7442 prophylaxis trial met primary endpoint
16/08/21	15:00:01	16 Aug 2021	Director/PDMR Shareholding	Director/PDMR Shareholding

Showing 451–457 of 457 announcements

Date	Time	Date	TitleTitle (filtered)
03/09/21	07:00:06	3 Sept 2021	Ultomiris approved in EU for children with PNH	Ultomiris approved in EU for children with PNH
01/09/21	15:00:06	1 Sept 2021	Total Voting Rights	Total Voting Rights
26/08/21	07:05:00	26 Aug 2021	Forxiga approved in Japan for CKD	Forxiga approved in Japan for CKD
26/08/21	07:00:02	26 Aug 2021	ALXN1840 Wilson Phase III met primary endpoint	ALXN1840 Wilson Phase III met primary endpoint
20/08/21	07:05:04	20 Aug 2021	Update on Ultomiris Phase III ALS trial	Update on Ultomiris Phase III ALS trial
20/08/21	07:00:09	20 Aug 2021	AZD7442 prophylaxis trial met primary endpoint	AZD7442 prophylaxis trial met primary endpoint
16/08/21	15:00:01	16 Aug 2021	Director/PDMR Shareholding	Director/PDMR Shareholding

Showing 451–457 of 457 announcements